The MagPro R30 is our most popular TMS device and is favoured by both private and NHS clinics across the United Kingdom. It has an advanced high performance magnetic stimulator designed for clinical use. Clinicians report that the Super Flex arm allows ease of use and accurate coil positioning. The cooled coil ensures patient safety and comfort. The MagPro R30 performs repetitive Transcranial Magnetic Stimulation (rTMS) and runs many complex protocols successively (up to 20,000 pulses).
The MagVita range of magnetic stimulators are the only TMS devices available in the UK that are CE approved for clinical use for the treatment of depression.
- “treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode"
Examination of the physiology of the motor pathways in the central and peripheral nervous system
Is often used within Transcranial Magnetic Stimulation (TMS) and repetitive Transcranial Magnetic Stimulation (rTMS) research
Stimulation rates up to 30 pulses per second.
60 pps option available.
System operation control via a built-in computer, eliminating the need for an external computer to set up and control the timing of stimulus sequences.
Flexible protocol storage.
User friendly software.
Quick protocol set-up and storage.
Easily connected to external equipment (like EMG system) via the In/Out triggers.
For more information about TMS for your hospital or clinic please fill out the contact form below or email email@example.com
In December 2015, the National Institute for Health and Care Excellence (NICE) approved rTMS (Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK. Repetitive Transcranial Magnetic Stimulation (rTMS) is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood. The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants. rTMS has also been shown effective in treating migraine, post-natal depression and pain.
The evidence on repetitive transcranial magnetic stimulation for depression shows no major safety concerns [...] repetitive transcranial magnetic stimulation for depression may be used with normal arrangements for clinical governance and audit.”
Ectron is pleased to announce it will be exhibiting at Therapy Expo,
Birmingham NEC on 22nd & 23rd November 2017. Come and visit us on stand TB63 and have a demonstration on the new PABLO from Tyromotion.
The PABLO Handsensor is a real allrounder: hand-arm-therapy and assessment device in one, the PABLO does not just facilitate the training of all grip forms of the hand; the built-in sensors also track the grip force and range of motion. Thanks to the cross-system tyroS software, the PABLO offers interactive motion training with audiovisual feedback. The results of each training session are automatically integrated into the data base and the therapy report.
With the following wireless extensions, the PABLO becomes even more versatile:
The PABLO Motionsensor is a precise joint assessment due to measurement modules that are attached to the body with loop straps of various sizes. Individual positioning of the Motionsensors enables a variety of therapies. So symmetric and asymmetric, bilateral and cooperative applications are possible.
The PABLO Multiball supports pronation and supination training as well as the flexion and extension of the wrist. Even at an early stage of rehabilitation, such as flaccid hemiparesis, the Multiball can be used for therapy of the upper extremities. To that end, the PABLO sensor handle is simply inserted into the PABLO Multiball. The hand is attached to the ball by means of a flexible strap system.
The PABLOMultiboard is used to guide and assist repetitive distal and proximal single- and multi-joint exercises. Even severely impaired patients can receive therapy with the Multiboard and learn to avoid compensations in movement from the get-go.